MIF inhibitors(L2 Diagnostics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMIF inhibitors(L2 Diagnostics)
Drug Alias NameMIF inhibitors(L2 Diagnostics)MIF inhibitors(L2 Diagnostics)macrophage migration inhibitory factor inhibitors(L2 Diagnostics)p425
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsDiabetes Mellitus, Type 1Arthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesL2 Diagnostics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesL2 Diagnostics LLC
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Arthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A